{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:31:16Z","timestamp":1791279076882,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"34","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,8,25]]},"DOI":"10.1038\/onc.2015.520","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T11:16:49Z","timestamp":1453720609000},"page":"4540-4548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis"],"prefix":"10.1038","volume":"35","author":[{"given":"C S","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T-K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H G","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Jeoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W R","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N K","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"BFonc2015520_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GCO.0000000000000034","volume":"26","author":"MC Teo","year":"2014","unstructured":"Teo MC . Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer. Curr Opin Obstet Gynecol 2014; 26: 3\u20138.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BFonc2015520_CR2","first-page":"613","volume":"82","author":"A Novoa-Vargas","year":"2014","unstructured":"Novoa-Vargas A . [Natural history of ovary cancer]. Ginecol Obstet Mex 2014; 82: 613\u2013622.","journal-title":"Ginecol Obstet Mex"},{"key":"BFonc2015520_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E . Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053\u20131064.","journal-title":"Am J Pathol"},{"key":"BFonc2015520_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-9966-31-14","volume":"31","author":"A Kim","year":"2012","unstructured":"Kim A, Ueda Y, Naka T, Enomoto T . Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 2012; 31: 14.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFonc2015520_CR5","doi-asserted-by":"crossref","unstructured":"Ovarian cancer, five-year stage-specific relative survival rates (2004-2008). J Natl Cancer Inst 2011; 103: 1287.","DOI":"10.1093\/jnci\/djr342"},{"key":"BFonc2015520_CR6","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s40265-014-0302-9","volume":"74","author":"GM Keating","year":"2014","unstructured":"Keating GM . Bevacizumab: a review of its use in advanced cancer. Drugs 2014; 74: 1891\u20131925.","journal-title":"Drugs"},{"key":"BFonc2015520_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1096\/fasebj.11.6.9194523","volume":"11","author":"HT Maecker","year":"1997","unstructured":"Maecker HT, Todd SC, Levy S . The tetraspanin superfamily: molecular facilitators. FASEB J 1997; 11: 428\u2013442.","journal-title":"FASEB J"},{"key":"BFonc2015520_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrc3640","volume":"14","author":"ME Hemler","year":"2014","unstructured":"Hemler ME . Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 2014; 14: 49\u201360.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015520_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrc2543","volume":"9","author":"M Zoller","year":"2009","unstructured":"Zoller M . Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9: 40\u201355.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015520_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0168-8278(01)00183-0","volume":"35","author":"K Kanetaka","year":"2001","unstructured":"Kanetaka K, Sakamoto M, Yamamoto Y, Yamasaki S, Lanza F, Kanematsu T et al. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol 2001; 35: 637\u2013642.","journal-title":"J Hepatol"},{"key":"BFonc2015520_CR11","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1073\/pnas.87.17.6833","volume":"87","author":"S Szala","year":"1990","unstructured":"Szala S, Kasai Y, Steplewski Z, Rodeck U, Koprowski H, Linnenbach AJ . Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci USA 1990; 87: 6833\u20136837.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015520_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1046\/j.1440-1746.2003.03182.x","volume":"18","author":"K Kanetaka","year":"2003","unstructured":"Kanetaka K, Sakamoto M, Yamamoto Y, Takamura M, Kanematsu T, Hirohashi S . Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol 2003; 18: 1309\u20131314.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFonc2015520_CR13","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1016\/j.ejca.2013.03.032","volume":"49","author":"S Yue","year":"2013","unstructured":"Yue S, Mu W, Zoller M . Tspan8 and CD151 promote metastasis by distinct mechanisms. Eur J Cancer 2013; 49: 2934\u20132948.","journal-title":"Eur J Cancer"},{"key":"BFonc2015520_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10585-008-9168-0","volume":"25","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Ran YL, Hu H, Pan J, Li ZF, Chen LZ et al. TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis 2008; 25: 537\u2013548.","journal-title":"Clin Exp Metastasis"},{"key":"BFonc2015520_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1541-7786.MCR-06-0384","volume":"5","author":"S Kuhn","year":"2007","unstructured":"Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P et al. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007; 5: 553\u2013567.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015520_CR16","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1158\/1078-0432.CCR-04-1935","volume":"11","author":"S Gesierich","year":"2005","unstructured":"Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 2005; 11: 2840\u20132852.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015520_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","volume":"33","author":"B Thibault","year":"2014","unstructured":"Thibault B, Castells M, Delord JP, Couderc B . Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev 2014; 33: 17\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2015520_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1200\/JCO.2008.16.8351","volume":"27","author":"S Lennon","year":"2009","unstructured":"Lennon S, Barton C, Banken L, Gianni L, Marty M, Baselga J et al. Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer. J Clin Oncol 2009; 27: 1685\u20131693.","journal-title":"J Clin Oncol"},{"key":"BFonc2015520_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1023\/A:1018762216147","volume":"4","author":"J Albanell","year":"1999","unstructured":"Albanell J, Baselga J . The ErbB receptors as targets for breast cancer therapy. J Mammary Gland Biol Neoplasia 1999; 4: 337\u2013351.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFonc2015520_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2559.2007.02897.x","volume":"52","author":"SJ Payne","year":"2008","unstructured":"Payne SJ, Bowen RL, Jones JL, Wells CA . Predictive markers in breast cancer\u2014the present. Histopathology 2008; 52: 82\u201390.","journal-title":"Histopathology"},{"key":"BFonc2015520_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000356202","volume":"89","author":"Y Okada","year":"2014","unstructured":"Okada Y, Miyamoto H, Goji T, Takayama T . Biomarkers for predicting the efficacy of anti-epidermal growth factor receptor antibody in the treatment of colorectal cancer. Digestion 2014; 89: 18\u201323.","journal-title":"Digestion"},{"key":"BFonc2015520_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","volume":"28","author":"A Bardelli","year":"2010","unstructured":"Bardelli A, Siena S . Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 2010; 28: 1254\u20131261.","journal-title":"J Clin Oncol"},{"key":"BFonc2015520_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fphys.2014.00364","volume":"5","author":"N Ailane","year":"2014","unstructured":"Ailane N, Greco C, Zhu Y, Sala-Valdes M, Billard M, Casal I et al. Effect of an anti-human Co-029\/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model. Front Physiol 2014; 5: 364.","journal-title":"Front Physiol"},{"key":"BFonc2015520_CR24","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1158\/1535-7163.MCT-07-0237","volume":"6","author":"H Huynh","year":"2007","unstructured":"Huynh H, Teo CC, Soo KC . Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. Mol Cancer Ther 2007; 6: 2959\u20132966.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2015520_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-9966-31-16","volume":"31","author":"Y Xu","year":"2012","unstructured":"Xu Y, Li Q, Li XY, Yang QY, Xu WW, Liu GL . Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis. J Exp Clin Cancer Res 2012; 31: 16.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFonc2015520_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-13-1349","volume":"74","author":"C Kudo-Saito","year":"2014","unstructured":"Kudo-Saito C, Yura M, Yamamoto R, Kawakami Y . Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Res 2014; 74: 1361\u20131370.","journal-title":"Cancer Res"},{"key":"BFonc2015520_CR27","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1038\/onc.2013.156","volume":"32","author":"MK Ki","year":"2013","unstructured":"Ki MK, Jeoung MH, Choi JR, Rho SS, Kwon YG, Shim H et al. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. Oncogene 2013; 32: 5449\u20135457.","journal-title":"Oncogene"},{"key":"BFonc2015520_CR28","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.4049\/jimmunol.1103803","volume":"189","author":"S Lee","year":"2012","unstructured":"Lee S, Yoon IH, Yoon A, Cook-Mills JM, Park CG, Chung J . An antibody to the sixth Ig-like domain of VCAM-1 inhibits leukocyte transendothelial migration without affecting adhesion. J Immunol 2012; 189: 4592\u20134601.","journal-title":"J Immunol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015520","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:16:42Z","timestamp":1647893802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":28,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,8,25]]}},"alternative-id":["BFonc2015520"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.520","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"assertion":[{"value":"15 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}